Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Intravenous Iron Dosing Schedules in Hemodialysis Patients with Absolute Iron Deficiency
TCTR20251231008Phase 2Recruiting
- Sponsor
- King Taksin Memorial Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Iron in iron deficiency anemia (IDA), chronic kidney disease (CKD), sponsored by King Taksin Memorial Hospital. Started Dec 2025; status: recruiting.
02
Drugs
Iron
03
Conditions
iron deficiency anemia (IDA)chronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20251231008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251231008.